scispace - formally typeset
N

Na Kong

Researcher at Brigham and Women's Hospital

Publications -  79
Citations -  6654

Na Kong is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 25, co-authored 54 publications receiving 3568 citations. Previous affiliations of Na Kong include Hangzhou Normal University & Harvard University.

Papers
More filters
Journal ArticleDOI

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

TL;DR: Understanding the novel function of autophagy may allow us to develop a promising therapeutic strategy to enhance the effects of chemotherapy and improve clinical outcomes in the treatment of cancer patients.
Journal ArticleDOI

p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents.

TL;DR: New insights are provided into p38 and JNK MAPK pathways function in the control of the balance of autophagy and apoptosis in response to genotoxic stress that will hopefully provide prospective strategies for cancer therapy.
Journal ArticleDOI

Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications

TL;DR: This tutorial review summarizes their general properties including the classification of Xenes according to their bulk properties, as well as the synthetic and modification methods of Xene.
Journal ArticleDOI

Two-Dimensional Antimonene-Based Photonic Nanomedicine for Cancer Theranostics.

TL;DR: A novel photonic drug‐delivery platform based on 2D PEGylated AM nanosheets (NSs) is developed, addressing several key limitations of cancer nanomedicines and marking an exciting jumping‐off point for research into the application of 2D AM nanomaterials in cancer theranostics.
Journal ArticleDOI

A Novel Top-Down Synthesis of Ultrathin 2D Boron Nanosheets for Multimodal Imaging-Guided Cancer Therapy.

TL;DR: This is the first report on the top‐down fabrication of ultrathin 2D B NSs by the combined thermal oxidation etching and liquid exfoliation, as well as their application as a multimodal imaging‐guided drug delivery platform.